“The legacy of thalidomide” ‐ A multidisciplinary meeting held at the University of York, United Kingdom, on September 30, 2016

Elizabeth Newbronner, Neil Vargesson, Karl Atkin

Open source

DOI: 10.1002/bdra.23619
Published: 2017-02-10
Container: Birth Defects Research
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/bdra.23619,
  title = {“The legacy of thalidomide” ‐ A multidisciplinary meeting held at the University of York, United Kingdom, on September 30, 2016},
  author = {Elizabeth Newbronner and Neil Vargesson and Karl Atkin},
  year = {2017},
  journal = {Birth Defects Research},
  doi = {10.1002/bdra.23619},
  url = {https://doi.org/10.1002/bdra.23619}
}

RIS

TY  - JOUR
TI  - “The legacy of thalidomide” ‐ A multidisciplinary meeting held at the University of York, United Kingdom, on September 30, 2016
AU  - Elizabeth Newbronner
AU  - Neil Vargesson
AU  - Karl Atkin
PY  - 2017
JO  - Birth Defects Research
DO  - 10.1002/bdra.23619
UR  - https://doi.org/10.1002/bdra.23619
ER  -

APA

Newbronner, E., Vargesson, N., & Atkin, K. (2017). “The legacy of thalidomide” ‐ A multidisciplinary meeting held at the University of York, United Kingdom, on September 30, 2016. Birth Defects Research. https://doi.org/10.1002/bdra.23619

Source records

crossref · retrieved 2026-11-10T21:37:09.667Z